Goodbody Health early detection substantially improves patient outcomes (Interview)

Goodbody Health Inc. (CSE: GDBY / AQSE: GDBY / FRA: 484 / OTC: SCNNF) Scientific Advisory Committee Member Dr Jamie Brosch joins DirectorsTalk Interviews to share his views on the company.

Jamie provides us with some background as a highly experienced GP, shares his views on Goodbody’s partnership with independent pharmacies supporting the over stretched NHS, how the company differs from others in the market, how blood tests will help an individual to start managing their health, thoughts on the GP referral scheme, how Jamie contributes to the Goodbody Scientific Advisory Committee and how results can impact on a person’s long term health.

Goodbody Health Inc. are a wellness company, focusing on the Health and Wellness of customers through the local community by the introduction and use of cutting edge diagnostic equipment.

You might also enjoy reading  Goodbody Health announces distribution agreement with Tasso
Find more news, interviews, share price & company profile here for:
Goodbody Health

Share this interview

Share on twitter
Share on linkedin
Share on facebook
Share on email
Share on whatsapp
Goodbody Health early detection substantially improves patient outcomes (Interview)

Other Interviews

More News

Ask your questions

Do you have questions you’d like to ask this company, get in touch and we’ll ask them for you.   

I have questions